Binaytara – shared on X:
“The Global Oncology session at SCHD25 packed multiple innovations into quick, impactful presentations. Dr. Shailender Bhatia‘s AFFORD-IO trial in Uganda, alongside insights from Dr. Vivian Oehler and Dr. Benjamin Li, demonstrates how we can make immunotherapy more accessible globally.”
The Binaytara Foundation highlighted key developments in global oncology during the SCHD25 session. Dr. Shailender Bhatia presented the AFFORD-IO trial from Uganda, and additional perspectives were shared by Dr. Vivian Oehler and Dr. Benjamin Li. The session emphasized innovative approaches to improving global access to immunotherapy.